OCLO LLC sold chlorine dioxide products, including OCLO 3000, as unapproved COVID-19 drugs, FDA and FTC say.
What happened
FDA and FTC reviewed the company’s website on April 15, 2021, along with a Facebook page and eCrater storefront. The review found chlorine dioxide products, including OCLO 3000, offered for sale with claims to prevent, treat, or cure COVID-19. FDA says the website was removed by the letter date, but the eCrater storefront continued to offer the products.
What FDA found
The chlorine dioxide products, including OCLO 3000, were sold as drugs to prevent or treat COVID-19 without FDA approval.
section 505(a) of the FD&C Act, 21 U.S.C. § 355(a)The products are misbranded—misleadingly labeled—because their labeling and promotion make misleading drug claims.
section 502 of the FD&C Act, 21 U.S.C. § 352The company put these products into interstate commerce, which the law prohibits for unapproved or misbranded drugs.
sections 301(a) and (d) of the FD&C Act, 21 U.S.C. § 331(a) and (d)The company advertised that its products can prevent, treat, or cure COVID-19 without competent and reliable scientific evidence.
FTC Act, 15 U.S.C. 41 et seq.
What FDA wants
FDA tells the company to immediately stop selling the unapproved COVID-19 products. Within 48 hours, the company must email FDA describing the specific steps taken and provide copies of related documents.
Who should pay attention
- online sellers of chlorine dioxide or 'MMS' products
- marketplaces that host COVID-19 treatment claims
- brands selling oral products with antiviral or immune-booster claims
This is a summary. Read the original letter on fda.gov.